{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19(7)"],"submitter":["Aparisi A"],"pubmed_abstract":["Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; <i>"],"journal":["International journal of environmental research and public health"],"pagination":["3961"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8997887"],"repository":["biostudies-literature"],"pubmed_title":["Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache."],"pmcid":["PMC8997887"],"pubmed_authors":["Iglesias-Echeverria C","Garcia-Azorin D","Aparisi A","Garcia-Gomez M","Marcos-Mangas M","Fernandez-de-Las-Penas C","Carrasco-Moraleja M","Ybarra-Falcon C","Valle-Penacoba G","Guerrero AL"],"additional_accession":[]},"is_claimable":false,"name":"Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache.","description":"Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; <i>","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-26T13:05:22.525Z","creation":"2025-04-06T14:09:35.663Z"},"accession":"S-EPMC8997887","cross_references":{"pubmed":["35409644"],"doi":["10.3390/ijerph19073961"]}}